Chembio received second UNICEF order for $15 Million
On Apr. 8, 2020, Chembio Diagnostics announced a second $1.5 million purchase order from UNICEF for multiplex Zika,…
CSL Behring and SAB Biotherapeutics joined forces to deliver new potential COVID-19 therapeutic
On Apr. 8, 2020, CSL Behring and SAB Biotherapeutics announced a partnership to combat the coronavirus pandemic with…
Texas A&M Researchers designed 3D-printed diffuser to treat COVID-19 patients
On Apr. 8, 2020, a team of Texas A&M University researchers led by Michael R. Moreno, in collaboration…
Biotechnology | COVID-19 | Diagnostics | FDA
InBios received EUA for its Smart Detect SARS-CoV-2 rRT-PCR Kit for detection of virus causing COVID-19
On Apr. 8, 2020, InBios announced that it had received Emergency Use Authorization (EUA) from the FDA for…
Biotechnology | COVID-19 | FDA | Therapeutics
Karyopharm to evaluate low dose Selinexor as potential treatment for hospitalized patients with COVID-19
On Apr. 7, 2020, Karyopharm Therapeutics announced plans to initiate a global randomized clinical trial for low dose…
Repurposing existing drugs could offer faster path to COVID-19 treatment
On Apr. 7, 2020, a map of interactions between the novel coronavirus and human proteins is helping scientists…
Pluristem reported preliminary data from COVID-19 Compassionate Use Program, treating seven patients with acute respiratory failure
On Apr. 7, 2020, Pluristem Therapeutics announced preliminary data from its compassionate use program, treating seven patients suffering…
Queensland University leads international team researching ancient Australian plant to help in production of COVID-19 vaccine
On Apr. 7, 2020, the Queensland University of Technology (QUT) announced that it is leading an international team…
COVID-19 | FDA | Therapeutics
Cumberland Pharma expanded availability of Vaprisol to treat Hyponatremia for critical care COVID-19 patients
On Apr. 7, 2020, Cumberland Pharma announced an initiative to increase availability of Vaprisol (conivaptan hydrochloride) injection for…
Mesa Biotech to ship 10,000 Accula SARS-CoV-2 tests for 30 minute rapid molecular point of care diagnosis
On Apr. 7, 2020, Mesa Biotech announced it was shipping 10,000 of its Accula SARS-CoV-2 molecular rapid point…
FDA approved Emory University human clinical trials for Emory COVID-19 antiviral
On Apr. 7, 2020, the U.S. Food and Drug Administration (FDA) approved an Investigational New Drug application by…
Successful MERS vaccine in mice may hold promise for COVID-19 vaccine
On Apr. 7, 2020, researchers at the University of Iowa and the University of Georgia announced they had…
Harvard, MIT and Stanford commited to COVID-19 technology licensing principles, maximizing access to innovations
On Apr. 7, 2020, Harvard University, Massachusetts Institute of Technology, and Stanford University announced they had established and…
Seattle area philanthropists responded to COVID-19 care and research needs
On Apr. 7, 2020, the University of Washington Medicine (UW) announced that more than $20 million has been…
Sema4 launched high-capacity COVID-19 testing to address critical need across Connecticut and New York
On Apr. 6, 2020, new COVID-19 estimated find that, among European nations, the peak daily death rate from…
AIM ImmunoTech announced NCI award of $14.54 million to study Ampligen as part of five Roswell Park-led chemokine modulation clinical trials in melanoma, colorectal and ovarian cancers
On Apr. 6, 2020, the National Cancer Institute awarded of $14.54 million to Roswell Park Comprehensive Cancer Center…
AIM ImmunoTech and Shenzhen Smoore Technology announced research agreement to develop, easy-to-use treatment approach for the SARS-CoV-2 Pandemic
On Apr. 6, 2020, AIM ImmunoTech announced a Material Transfer and Research Agreement (MTA) with Shenzhen Smoore Technology…
New antiviral drug from Emory University heading into clinical trials for COVID-19 treatment
On Apr. 6, 2020, Emory’s Vaccine and Treatment Evaluation Unit (VTEU) announced its participation in a clinical trial…
Innovation Pharma in discussions to advance Brilacidin into human trials against COVID-19
On Apr. 6, 2020, Innovation Pharma announced that it is engaged in discussions with health care provider networks…
3M and White House announced plan to import 166.5 million additional respirators into the U.S. over the next three months
On Apr. 6, 2020, 3M and the White House announced a plan to import 166.5 million respirators over…
University of Minnesota Twin Cities designed respirator mask prototypes from filter technology
On Apr. 6, 2020, to address the need for N95 masks, an interdisciplinary research team at the University…
3M partnered with Cummins to increase production of filters for powered air purifying respirators
On Apr. 6, 2020, 3M announced a partnership with Cummins to increase the production of high efficiency particulate…
Partners with hospitals nationwide to provide prioritized testing to inpatients with suspected COVID-19
On Apr. 6, 2020, BioReference Laboratories, an OPKO Health company, announced that it will continue to prioritize COVID-19…
CSL Group collaborated with global plasma leaders to accelerate development of COVID-19 hyperimmune therapy
On Apr. 6, 2020, Biotest, BPL Group, LFB, and Octapharma joined an alliance formed by CSL Behring and…
COVID-19 | FDA | Infectious Disease | Vaccine
INOVIO initiated phase 1 clinical trial of its COVID-19 vaccine
On Apr. 6, 2020, Inovio Pharma announced the U.S. Food and Drug Administration (FDA) had accepted the company’s…
OraSure Technologies received BARDA contract for Rapid Oral Fluid Pan-SARS-Coronavirus in-home self-test
On Apr. 6, 2020, OraSure Technologies announced it had been awarded a $710,310 contract from the Biomedical Advanced…
USDA confirmed COVID-19 in a tiger in New York Zoo
On Apr. 6, 2020, the USDA confirmed SARS-CoV-2 (the virus that causes COVID-19 in humans) in one tiger…
Luminex received FDA Emergency Use Authorization for ARIES SARS-CoV-2 assay to detect virus responsible for COVID-19 disease
On Apr. 6, 2020, Luminex announced announced that the FDA has issued an Emergency Use Authorization for its…
VGXI supported rapid timeline to clinical testing for Coronavirus vaccine
On Apr. 6, 2020, VGXI, announced it had completed manufacturing and release of a DNA vaccine to combat…
VGXI established pilot mRNA manufacturing capabilities
On Apr. 6, 2020, VGX announced successful implementation of new RNA production services through completion of all Phase…